Back
Goldman Sachs S&P 500 Core Prm IncETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
44
GPIX
Goldman Sachs S&P 500 Core Prm IncETF
Last Price:
48.66
Seasonality Move:
0%
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
259.70
Seasonality Move:
31.67%
Sell
44
Goldman Sachs S&P 500 Core Prm IncETF (GPIX)
is a Sell
Is Goldman Sachs S&P 500 Core Prm IncETF a Buy, Sell or Hold?
- The current Goldman Sachs S&P 500 Core Prm IncETF [GPIX] share price is $48.51. The Score for GPIX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- GPIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPIX Stock Price Chart
What is Goldman Sachs S&P 500 Core Prm IncETF's stock price today?
-
The Goldman Sachs S&P 500 Core Prm IncETF share price today is $48.51
The current trend is moderately bearish and GPIX is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 42.07 | Sell |
| Chaikin Money Flow: | -88500 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.66 - 49.4) | Sell |
| Bollinger Bands (100): | (46.92 - 48.9) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 74.74 | Buy |
| Chaikin Money Flow: | 898979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.29 - 223.91) | Buy |
| Bollinger Bands (100): | (221.8 - 277.54) | Buy |
GPIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.17 | Sell |
| 20-day SMA: | 49.12 | Sell |
| 50-day SMA: | 48.52 | Sell |
| 200-day SMA: | 46.89 | Buy |
| 8-day EMA: | 49.1 | Sell |
| 20-day EMA: | 49.05 | Sell |
| 50-day EMA: | 48.58 | Sell |
| 200-day EMA: | 46.68 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 216.22 | Buy |
| 20-day SMA: | 214.16 | Buy |
| 50-day SMA: | 227.04 | Buy |
| 200-day SMA: | 240.71 | Buy |
| 8-day EMA: | 223.2 | Buy |
| 20-day EMA: | 218.42 | Buy |
| 50-day EMA: | 226.38 | Buy |
| 200-day EMA: | 233.63 | Buy |
Goldman Sachs S&P 500 Core Prm IncETF Earnings Growth & GPIX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.
Goldman Sachs S&P 500 Core Prm IncETF Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||